Clinical Trials
Participating in research is one of the most powerful things you can do to be part of tomorrow's healthcare breakthroughs. Penn State Health is always looking for people who are willing to participate in studies, so that our researchers can better understand how to diagnose, treat, and prevent diseases and conditions.
Non-inferiority study of GSK3511294 compared with mepolizumab or benralizumab in participants with severe asthma with an eosinophilic phenotype.
...
Non-inferiority study of GSK3511294 compared with mepolizumab or benralizumab in participants with severe asthma with an eosinophilic phenotype.
...
Non-inferiority study of GSK3511294 compared with mepolizumab or benralizumab in participants with severe asthma with an eosinophilic phenotype.
...
Placebo-controlled efficacy and safety study of GSK3511294 in participants with severe asthma with an eosinophilic phenotype
...
Placebo-controlled efficacy and safety study of GSK3511294 in participants with severe asthma with an eosinophilic phenotype
...
Placebo-controlled efficacy and safety study of GSK3511294 in participants with severe asthma with an eosinophilic phenotype
...
We are asking you to take part in this voluntary research study because you have been diagnosed with systemic sclerosis. The study drug, ACE-1334, is being studied as a potential
...
We are asking you to take part in this voluntary research study because you have been diagnosed with systemic sclerosis. The study drug, ACE-1334, is being studied as a potential
...
This study is for patients 40-80 years of age with IPF (idiopathic pulmonary fibrosis). This study is being done to learn more about an experimental medication which is being developed
...
This is a drug study, that will evaluate the potential effectiveness of an investigational drug called pamrevlumab, compared to a placebo, in patients diagnosed with Idiopathic Pulmonary Fibrosis.
...